Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg bumps up target price on Anglo American ahead of Teck merger

(Sharecast News) - Analysts at Berenberg hiked its target price on mining giant Anglo American from 4,000p to 4,200p on Friday as it said the market was overlooking the consensus upside from its planned merger with Teck. Berenberg said it continues to believe investors were underestimating the underlying earnings potential of the combined Anglo-Teck business, with Chinese competition approvals now the final major hurdle before completion - which was expected to close between September 2026 and March 2027.

Once merged and following the disposal of non‑core assets, Berenberg said the new entity, to be known as Anglo Teck, will be dominated by copper, which was expected to account for roughly 74% of EBITDA. Iron ore and zinc will contribute roughly 15% and 8%, respectively, with the remainder coming from manganese.

Berenberg said the enlarged group would be a roughly 1.3mtpa copper producer, a profile it believes could command a premium multiple in the UK market.

The German bank argued that consensus forecasts did not yet reflect the economics of the combined business, stating a review of Visible Alpha estimates for both companies suggested the sell‑side was largely modelling them separately, whereas Berenberg's integrated model put its 2027-29 EBITDA forecasts approximately 6% ahead of consensus. Using consensus commodity prices, the broker said it would be 12% ahead on EBITDA over the same period.

Berenberg, which reiterated its 'buy' rating on the stock, added that once the deal completes and Anglo Teck holds a capital markets day, the market will likely recognise the embedded upside. .

"We make no changes to our model. We lift our price target to 4,200p per share (from 4,000p per share) as we roll forward our EBITDA and apply a 1.4x NAV multiple (from 1x) to reflect the premium NAV valuations seen in the sector currently. The shares are trading on 1.91x NAV and 7.6x 2027E EBITDA (based on a merged business), which we think is too cheap given premium peer valuations, and think that the shares can comfortably trade at 9-10x EBITDA," said Berenberg.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.